首页 | 本学科首页   官方微博 | 高级检索  
     

欧盟应对罕见病政策措施及其对中国的启示
引用本文:林禹鸿,吴晓明. 欧盟应对罕见病政策措施及其对中国的启示[J]. 浙江社会科学, 2011, 0(10)
作者姓名:林禹鸿  吴晓明
作者单位:1. 中国药科大学国际医药商学院
2. 中国药科大学,南京,210009
基金项目:2009年度中国药科大学中央高校基本科研业务费专项资金资助项目,编号JKQ2009029
摘    要:本文详细介绍了欧盟为应对罕见病所采取的包括提高对罕见病的认识水平、支持成员国应对罕见病的计划、加强成员国在罕见病领域的合作、建立罕见病的网络、鼓励罕见病研究、激励罕用药研发等在内的诸多政策,在此基础上简要分析了欧盟经验对中国的启示.

关 键 词:罕见病  罕用药

The Disclosure on EU Policies and Measures of Rare Diseases and Its Implications for China
Lin Yuhong,Wu Xiaoming. The Disclosure on EU Policies and Measures of Rare Diseases and Its Implications for China[J]. Zhejiang Social Sciences, 2011, 0(10)
Authors:Lin Yuhong  Wu Xiaoming
Affiliation:Lin Yuhong,Wu Xiaoming(Business School of International Medicine,China Pharmaceutical University,Nanjing 210009)
Abstract:This paper described a number of policies that European Union adopted in response to rare diseases in details,including improve the awareness level for rare diseases,and support member states' rare diseases strategies,strengthen their cooperation in this field,establish the rare diseases network and encourage the study on rare diseases as well as the development of orphan drugs,then took them as the basis to evaluate the effects on the implementation of EU policies with a view to China's future policy recom...
Keywords:Rare Diseases  Orphan Drugs  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号